- Home
- TOPS vs EDVA Comparison
TOPS vs EDVA Comparison
Compare TOPS & EDVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TOPS | EDVA |
|---|---|---|
| Founded | 2000 | N/A |
| Country | Greece | United States |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Beverages (Production/Distribution) |
| Sector | Consumer Discretionary | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.2M | 1.8M |
| IPO Year | 2004 | 2012 |
Fundamental Metrics
Financial Performance| Metric | TOPS | EDVA |
|---|---|---|
| Price | $0.30 | $0.17 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 594.9K | 557.7K |
| Earning Date | 09-16-2026 | 11-28-2026 |
| Dividend Yield | ★ 287.62% | N/A |
| EPS Growth | N/A | ★ 32.30 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $73,066.00 |
| Revenue This Year | N/A | $24,377.87 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $2.14 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.27 | $0.13 |
| 52 Week High | $7.40 | $0.33 |
Technical Indicators
Market Signals| Indicator | TOPS | EDVA |
|---|---|---|
| Relative Strength Index (RSI) | 22.20 | 42.70 |
| Support Level | N/A | $0.15 |
| Resistance Level | $1.29 | $0.18 |
| Average True Range (ATR) | 0.04 | 0.01 |
| MACD | -0.01 | 0.01 |
| Stochastic Oscillator | 10.24 | 67.11 |
Price Performance
Historical ComparisonAbout TOPS TOP Ships Inc.
TOP Ships Inc owns tanker vessels throughout the world. The Company is an international owner and operator of modern, fuel-efficient eco-tanker vessels, focusing on the transportation of crude oil, petroleum products (both clean and dirty), and bulk liquid chemicals. It generates revenue from the Time Charter agreements. The company operates in two reportable segments: (i) the tanker segment and (ii) the megayacht segment.
About EDVA Endovia Health Sciences Inc. Common Stock
Endovia Health Sciences Inc is building a diversified cannabinoid health sciences platform through pharmaceutical innovation, strategic partnerships and disciplined execution. Endovia acquires, develops and commercializes differentiated cannabinoid health technologies across pharmaceutical, veterinary and consumer wellness markets. Endovia's product begins with CannEpil, a cannabinoid pharmaceutical asset, and extends into veterinary development and consumer wellness as the pipeline expands.